Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Per Os Biosciences is a private U.S. healthcare products developer and manufacturer focused on novel oral dosage forms, especially tableted chewing gum, chewable tablets, lozenges, mints, and related confectionery-style delivery systems. The company positions itself as a specialized developer and contract manufacturer for dietary supplements, functional products, medicated chewing gum, and certain pharmaceutical concepts using a patented direct-compression process designed to improve content uniformity and preserve active ingredients. Its platform emphasizes buccal and oral delivery, room-temperature GMP manufacturing, and custom formulation of active ingredients including cannabinoids and oral care actives. Per Os Biosciences appears to operate primarily as a platform-enabled manufacturer and product development partner rather than as a traditional clinical-stage therapeutics company. Its known intellectual property includes manufacturing methods for medicated chewing gum and oral compositions involving cannabinoids, oral care, and antiviral or antimicrobial oral formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Per Os Biosciences.